Real-time enrollment status for this von willebrand disease (vwd) clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 8:34 PM UTC
| NCT Number | NCT06754852 |
| Recruiting Status | Recruiting |
| Condition | Von Willebrand Disease (VWD) |
| Phase | PHASE1 |
| Target Enrollment | 108 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Hemab ApS |
| Last Updated on CT.gov | June 30, 2026 (Jun 30, 2026) |
As of August 27, 2026: Clinical trial NCT06754852 is currently recruiting participants. This phase1 study for von willebrand disease (vwd) is actively seeking new participants at 13 locations across the United States. The study is sponsored by Hemab ApS. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06754852 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06754852 was last updated Jun 30, 2026 (June 30, 2026). HelloStudys verifies this status automatically.